Product image of Ofloxacine Viatris (Ofloxacin) supplied by GNH India

Ofloxacine Viatris

Active Ingredient:
Ofloxacin
Origin:
EU

Ofloxacine Viatris (Ofloxacin)

Ofloxacin, the active ingredient in Ofloxacine Viatris, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH India supplies Ofloxacine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Sante

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ofloxacine Viatris is a broad‑spectrum fluoroquinolone indicated for bacterial infections affecting several organ systems:

  • Urinary tract infections: helps eradicate common uropathogens and relieve symptoms.
  • Respiratory tract infections: effective against typical community‑acquired pathogens causing bronchitis and sinusitis.
  • Skin and soft‑tissue infections: combats susceptible Staphylococcus aureus and Streptococcus species to promote healing.

How It Works

  • Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription and repair. By stabilising the enzyme‑DNA complex, it prevents strand re‑ligation, leading to bacterial cell death and a bactericidal effect against susceptible Gram‑negative and Gram‑positive organisms.

Side Effects

Ofloxacine Viatris may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nausea: mild stomach upset reported by some patients.
  • Diarrhea: loose stools occurring during treatment.
  • Headache: transient head pain without neurological signs.
  • Dizziness: occasional light‑headed sensation.
  • Rash: mild skin redness or itching.
  • Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects

  • Tendon rupture: sudden tendon pain or rupture, especially in the Achilles.
  • QT interval prolongation: heart rhythm changes detectable on ECG.
  • Severe allergic reactions: anaphylaxis, angioedema or bronchospasm.
  • Peripheral neuropathy: numbness or tingling in extremities.
  • Hepatotoxicity: elevated liver enzymes or jaundice.
  • Clostridioides difficile infection: severe colitis following antibiotic use.

Precautions & Warnings

Before prescribing Ofloxacine Viatris, clinicians should consider several safety aspects:

  • Pregnancy: avoid use unless clearly needed, as fetal risk cannot be excluded.
  • Breastfeeding: assess risk versus benefit; small amounts may pass into milk.
  • Tendon disorders: discontinue if tendon pain, swelling or rupture occurs.
  • Cardiac risk: monitor patients with known QT prolongation or electrolyte imbalance.
  • Renal impairment: adjust dosing in severe kidney dysfunction.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Ofloxacine Viatris can interact with several medicines, altering efficacy or safety:

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce ofloxacin absorption.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of central nervous system stimulation.
  • Warfarin: may enhance anticoagulant effect and raise bleeding risk.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: combined use may raise tendon‑rupture risk.
  • Diabetic agents: ofloxacin may affect blood glucose control.
  • Theophylline: plasma concentrations can rise, requiring dose adjustment.

Frequently Asked Questions

Ofloxacine Viatris contains ofloxacin, a fluoroquinolone antibiotic that is prescribed for a range of bacterial infections such as urinary tract infections, community‑acquired respiratory infections and skin or soft‑tissue infections caused by susceptible organisms.

Ofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes that unwind and reseal DNA during replication. This inhibition prevents bacterial DNA synthesis, leading to cell death and a bactericidal effect against many Gram‑negative and Gram‑positive pathogens.

The dosage of Ofloxacine Viatris is determined by the prescribing clinician based on the type and severity of infection, patient age, weight and kidney function. Patients should follow the exact regimen provided by their healthcare professional.

Ofloxacin is classified as pregnancy category C in many regions; it should be used only if the potential benefit justifies the potential risk to the fetus. Small amounts can be excreted in breast milk, so a risk‑benefit assessment is required before use while breastfeeding.

To request Ofloxacine Viatris, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ofloxacine Viatris (ofloxacin) shares the class‑wide mechanism of DNA‑gyrase inhibition with other fluoroquinolones such as ciprofloxacin and levofloxacin. Ofloxacin offers a broad spectrum against both Gram‑negative and Gram‑positive bacteria, and its dosing flexibility can be advantageous in certain infections, though safety profiles are similar across the class.

Store Ofloxacine Viatris tablets at temperatures below 25 °C in their original container, protected from moisture and direct sunlight. Do not expose the product to excessive heat or humidity to maintain potency.

Ofloxacine Viatris is supplied as oral tablets that are taken with a full glass of water. The tablets may be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminum or magnesium, which can impair absorption.

Serious adverse reactions include tendon rupture, especially of the Achilles tendon, QT‑interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, peripheral neuropathy and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if these events occur.

Ofloxacine Viatris is contraindicated in patients with a known hypersensitivity to ofloxacin or other fluoroquinolones, and should be used with caution in individuals with a history of tendon disorders, cardiac arrhythmias, or severe renal impairment. Pregnant women should only use it when clearly indicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ofloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT